Mirror of the Market · Fair Comment · Public Interest · Not Medical Advice · Appeals Process

Peptide Supply Chain Audit · 12 US Providers
Where Does Your
Peptide Dollar Go?
We mapped the supply chain of every major peptide provider we could find. For every dollar you spend, here's where it actually goes — and what that tells you about who to trust.
How to Read This
Every dollar you spend on peptides gets divided among seven categories. The distribution tells you what the company actually values. High manufacturing + high physician oversight = they're investing in the product and your safety. High marketing + high profit = you're funding their Instagram ads and shareholder returns.
Provider Rankings
What to Look For
Green Flags
- Manufacturing > 15% of cost
- Physician oversight > 15%
- Active R&D / clinical trials
- Transparent about sourcing
- Compounding pharmacy partnerships
Red Flags
- Marketing > 30% of cost
- Zero physician allocation
- Celebrity endorsement premium
- "Research use only" disclaimers
- No published protocols or outcomes
Know What You're Buying
Take the Peptide Clarity Index™ — the only assessment that screens for contraindications, cites evidence, and gives you personalized results. Not a lead generation form.
For Manufacturers & Suppliers
Join Our Vetted Supply Network
We are onboarding 400+ naturopathic clinics and selectively expanding our approved vendor base. If your manufacturing meets our transparency and quality standards, we want to hear from you.
Become a Supply PartnerThis site is where you read and learn. Business engagement — supplier applications, buyer onboarding, CoA verification, and distribution partnerships — happens at ramprate.com/biochain.
Methodology Note: Cost breakdowns are estimated based on publicly available information, industry benchmarks, SEC filings (where applicable), and interviews with compounding pharmacists and telehealth operators. Actual cost structures may vary. Credibility scores weight manufacturing allocation (25%), physician oversight (25%), R&D investment (20%), compliance spend (15%), and transparency (15%). This page is for educational purposes only and does not constitute financial or medical advice. Data current as of February 2026.